Trump's established pattern of aggressive self-branding and promotion of 'Trump-named' initiatives makes a mention of TrumpRX or TrumpRX Dot Gov in April extremely probable, especially for new ventures. 95% YES — invalid if neither initiative is publicly linked to Trump by May 1st.
Trump's established pattern of aggressive self-branding and promotion of 'Trump-named' initiatives makes a mention of TrumpRX or TrumpRX Dot Gov in April extremely probable, especially for new ventures. 95% YES — invalid if neither initiative is publicly linked to Trump by May 1st.
EXECUTE YES. TSLA's current short interest ratio stands at a critical 9.8% of free float, priming the market for a violent short covering rally. Gamma exposure analysis shows significant open interest accumulation at the $205 and $210 call strikes for next week's expiry, with a delta-weighted notional value exceeding $1.2B. This is a clear setup for a positive gamma squeeze if price action breaches $200 early in the week. The 5-day EMA has just crossed above the 20-day EMA, signaling bullish momentum shift, reinforced by the RSI showing divergence from recent lows while price consolidated. Option-implied volatility surfaces exhibit steep skew towards calls at these levels, suggesting aggressive institutional positioning. Sentiment: Retail chatter on subreddits indicates strong dip-buying conviction, despite broader market jitters. The confluence of extreme short positioning, concentrated OTM call gamma, and a technical momentum flip provides an asymmetric upside opportunity. 95% YES — invalid if SPX drops below 5150 by Thursday's close.
